TY - JOUR
T1 - EBV-miR-BART1-5P activates AMPK/mTOR/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma
AU - Lyu, Xiaoming
AU - Wang, Jianguo
AU - Guo, Xia
AU - Wu, Gongfa
AU - Jiao, Yang
AU - Faleti, Oluwasijibomi Damola
AU - Liu, Pengfei
AU - Liu, Tielian
AU - Long, Yufei
AU - Chong, Tuotuo
AU - Yang, Xu
AU - Huang, Jing
AU - He, Mingliang
AU - Tsang, Chi Man
AU - Tsao, Sai Wah
AU - Wang, Qian
AU - Jiang, Qiang
AU - Li, Xin
PY - 2018/12
Y1 - 2018/12
N2 - Abnormal metabolism and uncontrolled angiogenesis are two important characteristics of malignant tumors. The occurrence of both events involves many key molecular changes including miRNA. However, EBV encoded miRNAs are rarely mentioned as capable of regulating tumor metabolism and tumor angiogenesis. Here, we reported that one of the key miRNAs encoded by EBV, EBV-miR-Bart1-5P, can significantly promote nasopharyngeal carcinoma (NPC) cell glycolysis and induces angiogenesis in vitro and in vivo. Mechanistically, EBV-miR-Bart1-5P directly targets the α1 catalytic subunit of AMP-activated protein kinase (AMPKα1) and consequently regulates the AMPK/mTOR/HIF1 pathway which impelled NPC cell anomalous aerobic glycolysis and angiogenesis, ultimately leads to uncontrolled growth of NPC. Our findings provide new insights into metabolism and angiogenesis of NPC and new opportunities for the development of targeted NPC therapy in the future.
AB - Abnormal metabolism and uncontrolled angiogenesis are two important characteristics of malignant tumors. The occurrence of both events involves many key molecular changes including miRNA. However, EBV encoded miRNAs are rarely mentioned as capable of regulating tumor metabolism and tumor angiogenesis. Here, we reported that one of the key miRNAs encoded by EBV, EBV-miR-Bart1-5P, can significantly promote nasopharyngeal carcinoma (NPC) cell glycolysis and induces angiogenesis in vitro and in vivo. Mechanistically, EBV-miR-Bart1-5P directly targets the α1 catalytic subunit of AMP-activated protein kinase (AMPKα1) and consequently regulates the AMPK/mTOR/HIF1 pathway which impelled NPC cell anomalous aerobic glycolysis and angiogenesis, ultimately leads to uncontrolled growth of NPC. Our findings provide new insights into metabolism and angiogenesis of NPC and new opportunities for the development of targeted NPC therapy in the future.
UR - https://www.scopus.com/pages/publications/85059290598
UR - https://www.scopus.com/pages/publications/85059290598#tab=impact
U2 - 10.1371/journal.ppat.1007484
DO - 10.1371/journal.ppat.1007484
M3 - RGC 21 - Publication in refereed journal
C2 - 30557400
SN - 1553-7366
VL - 14
JO - PLoS Pathogens
JF - PLoS Pathogens
IS - 12
M1 - e1007484
ER -